Cannabis

Medical Marijuana, Inc. Subsidiary Kannaway® Receives BSCG Certified Drug-Free Approval for Its Pure Gold CBD

Retrieved on: 
Wednesday, February 24, 2021
Drugs, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Organ systems, Cannabis

This certification furthers our dedication to providing athletes and general consumers alike the confidence to enjoy Pure Gold CBD without the fear of drug testing.

Key Points: 
  • This certification furthers our dedication to providing athletes and general consumers alike the confidence to enjoy Pure Gold CBD without the fear of drug testing.
  • Medical Marijuana, Inc.s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.s shop.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

How California Is Dominating the Cannabis Brand Landscape

Retrieved on: 
Wednesday, February 24, 2021
OTC Markets Group, Cannabis

California is well known for its brand dominance-from its Hollywood studios to its Napa Valley wines.

Key Points: 
  • California is well known for its brand dominance-from its Hollywood studios to its Napa Valley wines.
  • More and more cannabis brands-in California and across the country-are expanding their product mix to include these new offerings.
  • Let's take a look at how California is dominating the cannabis brand landscape and companies that investors may want to consider for exposure, including FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and its unique business model.
  • The company's royalty portfolio includes two innovative companies that are developing cannabis brands in California, including Cultivation Technologies Inc. and QVI Inc .

Amfil Technologies, Inc. (OTC:FUNN) CEO Update on Canadian Cannabis Dispensary Initiative

Retrieved on: 
Wednesday, February 24, 2021
Psychoactive drugs, Cannabis law, Drug control law, Cannabis shop, Drug culture, Legality of cannabis, Cannabis, Underground culture

Projected timeline to open the first location is approximately 3 months pending buildout and transfer of the operators license and location permit.

Key Points: 
  • Projected timeline to open the first location is approximately 3 months pending buildout and transfer of the operators license and location permit.
  • The cannabis industry continues to thrive in Canada and the world at large.
  • More and more countries and territories are updating their regulations and permit the Cannabis industry to expand.
  • FUNN is aided with the consulting help of experienced and licensed cannabis dispensary operator, David Berkovits, to create and manage operations for the Companys new cannabis dispensary division.

The Parent Company to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, February 24, 2021
Alternative medicine, Agriculture, Health, Natural Resources, OTC Markets Group, Cannabis, Branches of biology

Investors and interested parties may listen to a webcast of the panel by visiting the Investor section of the Companys website at www.theparent.co .

Key Points: 
  • Investors and interested parties may listen to a webcast of the panel by visiting the Investor section of the Companys website at www.theparent.co .
  • The Parent Company (TPCO Holding Corp.) (NEO: GRAM.U, GRAM.WT.U) (OTCQX: GRAMF; OTC PINK: GRMWF) is Californias leading vertically integrated cannabis company combining best-in-class operations with leading voices in popular culture and social impact.
  • The Parent Company brings together global icon and entrepreneur Shawn JAY-Z Carter, entertainment powerhouse ROC NATION, Californias leading direct-to-consumer platform CALIVA, and leading cannabis and hemp manufacturer, LEFT COAST VENTURES, to form a cannabis industry leader for the post-prohibition era.
  • The brands we build together will pave a new path forward for a legacy rooted in equity, access, and justice.

Next Frontier Brands' Subsidiary Treehouse Biotech Submits Novel Foods Application to the U.K. Food Standards Agency

Retrieved on: 
Wednesday, February 24, 2021
European Union law, Food law, Food science, Novel food, Cannabis, Articles, Branches of biology, Health

BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ --Next Frontier Brands, a leading fast-moving consumer goods (FMCG) company, today announced the submission of a Novel Foods Application to the Food Standards Agency (FSA) in the United Kingdom (U.K.).

Key Points: 
  • BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ --Next Frontier Brands, a leading fast-moving consumer goods (FMCG) company, today announced the submission of a Novel Foods Application to the Food Standards Agency (FSA) in the United Kingdom (U.K.).
  • The application, which was submitted by Next Frontier Brands' subsidiary Treehouse Biotech, is the company's latest move to capture the growing market for hemp-derived CBD-infused foods and beverages in the U.K.
  • This Novel Foods Application establishes Treehouse Biotech as a global supplier of cGMP-quality cannabinoid ingredients.
  • "The submission of this Novel Foods Application supports our goal of establishing Treehouse Biotech as a global supplier of cGMP-quality cannabinoid ingredients and finished products to the food, beverage and wellness industries," said Shannon Soqui, Chief Executive Officer of Next Frontier Brands.

Next Frontier Brands' Subsidiary Treehouse Biotech Submits Novel Foods Application to the U.K. Food Standards Agency

Retrieved on: 
Wednesday, February 24, 2021
Euphoriants, Appetite stimulants, Entheogens, Cannabinoid, Hemp, Cannabis, Branches of biology, Applied sciences, Botany

"The U.K. novel food regulations require that all products containing CBD extracts and isolates must be sourced from an FSA-validated supplier," said Jake Black, Ph.D., Chief Scientific Officer of Treehouse Biotech.

Key Points: 
  • "The U.K. novel food regulations require that all products containing CBD extracts and isolates must be sourced from an FSA-validated supplier," said Jake Black, Ph.D., Chief Scientific Officer of Treehouse Biotech.
  • This positions Treehouse Biotech to become the vendor of choice for U.K. brands seeking an FSA-validated cGMP-quality supplier of high-quality CBD ingredients."
  • Established in 2016, Treehouse Biotech is a leader in the research, development and production of hemp-derived cannabinoid ingredients,and purification and remediation technologies.
  • Treehouse Biotech holds a portfolio of patents and patent applications covering the extraction and synthesis of various cannabinoids, including US Patent No.

Cannbit, subsidiary of Tikun Olam-Cannbit, and Canonic of Evogene group announce collaboration for the development of novel medical cannabis products

Retrieved on: 
Wednesday, February 24, 2021
Medicinal plants, Entheogens, Euphoriants, Herbalism, Cannabis, Health sciences, Branches of biology, Evogene, Rehovot, Tikun Olam, Tel Aviv Stock Exchange, Medical cannabis

TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), focused on the development of medical cannabis products, today announced that they have entered into a collaboration agreement for the development of novel medical cannabis products.

Key Points: 
  • TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), focused on the development of medical cannabis products, today announced that they have entered into a collaboration agreement for the development of novel medical cannabis products.
  • The development of the new products will be performed at Canonic's R&D facility and will be based on cannabis strains that both companies will contribute to the collaboration.
  • The company's strategy includes the development of cannabis strains in order to commercialize medical cannabis products independently or through collaborations.
  • Canonic has exclusive access to Evogene's genomic assets and technology for the development of medical cannabis products.

Cannbit, subsidiary of Tikun Olam-Cannbit, and Canonic of Evogene group announce collaboration for the development of novel medical cannabis products

Retrieved on: 
Wednesday, February 24, 2021
Medicinal plants, Entheogens, Euphoriants, Herbalism, Cannabis, Health sciences, Branches of biology, Evogene, Rehovot, Tikun Olam, Tel Aviv Stock Exchange, Medical cannabis

TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), focused on the development of medical cannabis products, today announced that they have entered into a collaboration agreement for the development of novel medical cannabis products.

Key Points: 
  • TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), focused on the development of medical cannabis products, today announced that they have entered into a collaboration agreement for the development of novel medical cannabis products.
  • The development of the new products will be performed at Canonic's R&D facility and will be based on cannabis strains that both companies will contribute to the collaboration.
  • The company's strategy includes the development of cannabis strains in order to commercialize medical cannabis products independently or through collaborations.
  • Canonic has exclusive access to Evogene's genomic assets and technology for the development of medical cannabis products.

The Valens Company Submits Site Evidence Package to Health Canada for Manufacturing Facility in Greater Toronto Area

Retrieved on: 
Tuesday, February 23, 2021
Ancient Romans, Gothic War, Hod HaSharon, Valens, Cannabis, OTC Markets Group, Roman emperors

KELOWNA, BC, Feb. 23, 2021 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has submitted a site evidence package to Health Canada under its existing micro-processing licence application for the Company's third facility in Canada, located in the Greater Toronto Area ("GTA Facility").

Key Points: 
  • KELOWNA, BC, Feb. 23, 2021 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that it has submitted a site evidence package to Health Canada under its existing micro-processing licence application for the Company's third facility in Canada, located in the Greater Toronto Area ("GTA Facility").
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.
  • The Valens Company cautions you not to place undue reliance upon any such forward-looking statements.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

GreenBroz Announces Strategic Partnership With Brother Gearmotor

Retrieved on: 
Tuesday, February 23, 2021
Entheogens, Euphoriants, Medicinal plants, Cannabis, Herbs, Plants, Branches of biology, Pharmacognosy

LAS VEGAS, Feb. 23, 2021 /PRNewswire/ -- Greenbroz Inc., the global leader in cannabis post-harvest processing technology, is proud to announce an expanded strategic partnership with Brother Gearmotor, a division of Brother International Corporation, for the use of their gearmotors and expertise in the production of GreenBroz products.

Key Points: 
  • LAS VEGAS, Feb. 23, 2021 /PRNewswire/ -- Greenbroz Inc., the global leader in cannabis post-harvest processing technology, is proud to announce an expanded strategic partnership with Brother Gearmotor, a division of Brother International Corporation, for the use of their gearmotors and expertise in the production of GreenBroz products.
  • Notably, GreenBroz is the first company in the cannabis industry that Brother Gearmotor deals with directly.
  • "The relationship between Brother Gearmotor and GreenBroz goes far beyond superior products," said Schyler Kaminski, Regional Sales Manager, Brother Gearmotor Division.
  • The collaboration expands upon a relationship begun last year with the successful introduction of Brother gearmotors customized for use in the GreenBroz Model M Dry Trimmer.